SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the activity and safety of Oxaliplatin and S-1 (SOX) and
Oxaliplatin and Capecitabine (XELOX) in patients with peritoneal metastasis of colorectal
cancer.